Filter
387
Text search:
mutation
Featured
Recommendations
49
New Publications
95
Language
Document type
No document type
191
Guidelines
76
Studies & Reports
59
Manuals
18
Strategic & Response Plan
12
Fact sheets
12
Training Material
9
Videos
4
Situation Updates
3
Resource Platforms
2
Brochures
1
Countries / Regions
India
23
Global
11
Western and Central Europe
10
Africa
10
Ethiopia
9
South Africa
9
Burkina Faso
7
Cameroon
7
Latin America and the Carribbean
7
Senegal
6
Congo, Democratic Republic of
6
Haiti
6
Germany
6
Nigeria
5
Nepal
5
Tanzania
4
Benin
4
Liberia
3
Mali
3
Zambia
3
Namibia
3
Middle East and North Africa
3
Eastern Europe
3
Guinea
2
Sierra Leone
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Uganda
2
Niger
2
Chad
2
Kenya
2
Rwanda
2
Bangladesh
2
Mozambique
2
Brazil
2
Bolivia
2
Madagascar
2
Russia
2
France
2
Saudi Arabia
1
Togo
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Syria
1
Cambodia
1
Thailand
1
China
1
Indonesia
1
Mauritania
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
Botswana
1
El Salvador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Chile
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Asia
1
Venezuela
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
123
Clinical Guidelines
53
Public Health
26
Pharmacy & Technologies
13
Key Resources
8
Women & Child Health
6
Capacity Building
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
65
TB
50
HIV
25
AMR
22
Rapid Response
15
Mental Health
15
Pharmacy
15
Planetary Health
11
NTDs
11
Ebola
10
NCDs
9
Refugee
7
Caregiver
6
Disability
4
Polio
2
Zika
2
Natural Hazards
1
Specific Hazards
1
A COVID-19 virus mutation tracker system (CovMT; appendix) based on SARS-CoV-2 isolate genomes deposited to GISAID to track the worldwide sequencing efforts and the evolution of the mutational landscape of this virus. CovMT, which is updated daily,
...
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se réplique – et plus il est susceptible de muter. En
...
Cystic fibrosis (CF) was earlier thought to be a disease prevalent in the West among Caucasians. However, quite a number of recent studies have uncovered CF cases outside of this region, and reported hundreds of unique and novel variant forms of CFTR. Here, we discuss the evidence of CF in parts of
...
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se réplique – et plus il est susceptible de muter. L
...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var
...
doi: https://doi.org/10.1101/2020.10.28.20221143
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
Vertreter besorgniserregender Virusvarianten (variants of concern, kurz VOC) wurden weltweit aber auch in Europa, identifiziert. Molekularbiologische Details zu den Varianten sind unter SARS-CoV-2: Virologische Basisdaten und Virusvarianten abrufbar.
Il est plus essentiel que jamais d’assurer un accès équitable aux vaccins contre la COVID-19 pour faire face à l’évolution de la pandémie. Si le virus est éliminé dans certaines régions du monde alors qu’il se propage largement dans d’autres régions, nous courons tous le risque que
...
Updated 28 January 2020
Variants
recommended
updated regularly
21 Dec 2021. Slideset updated regularly to include the latest data and guidance on COVID-19 vaccines, including implications of emerging SARS-CoV-2 variants
How concerned should we be about the new variants of SARS CoV 2 which cause COVID-19? Is it unusual for viruses to change and mutate? Do vaccines protect against these variants and what can you do to protect yourself? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5
Weekly epidemiological update on COVID-19, 28 September 2022
The NY Times variant tracker is perhaps the most accessible and relevant publication for non-molecular biologists and the general public
Each coronavirus contains nearly 30,000 letters of RNA. This genetic information allows the virus to infect cells and hijack them to make new viruses.
